GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines. With 30 crore prescriptions annually, GSK aims to innovate and grow its portfolio, highlighting price strategies catering to a broad market range, from general medicines to high-value therapies.
Related Posts
India’s current economic environment conducive for private investments: CII survey
- staff
- January 19, 2025
- 0
India’s economic environment is favorable for private investments, revealing a bright outlook despite global challenges, according to a CII survey. It indicates a significant increase […]
Budget 2025 income tax new versus old regime: Top 7 expectations of taxpayers from FM Sitharaman
- staff
- January 28, 2025
- 0
Budget 2025 income tax expectations: While it is well known that new income tax regime is simplified tax regime without tax exemptions and deductions but […]
Core US inflation eases a fourth month, sealing Fed rate cut
In July, the core consumer price index in the US rose 3.2% from a year ago, marking a four-month decline in underlying inflation. Monthly, it […]